ISIDORe : Integrated Services for Infectious Disease Outbreak Research

ISIDORe provides an integrated portfolio of cutting-edge research services and resources to study epidemic-prone pathogens including SARS-CoV-2 
Read more

Free Access to high-containment facilities & resources through ISIDORe project

"Integrated Services for Infectious Disease Outbreak Research" ...
Read more

Risk group 4 pathogens call for proposals Pre-application deadline 03 February 2023, 23.59 CET

Get free of charge access to state-of-the-art facilities, cutting-edge services, for your research
Read more

European Research Infrastructure on Highly Pathogenic Agents

Access to leading European high containment (BSL4 laboratories) & complementary facilities
Read more

Our Services for COVID-19 research

Learn more on access opportunities to our BSL3 and complementary facilities
Read more

Follow our twitter: @ERINHA_RI

You can contact us here

Access to our intranet here

Download our portfolio here

Science Services

Erinha offers in-person and remote access to high containment facilities and expertise allowing scientists to advance research on highly pathogenic agents

Read more

Training

ERINHA provides biosecurity and biosafety trainings, including working safely in high containment conditions, operating and maintaining high containment (BSL3 & BSL4) facilities

Read more

Covid-19

ERINHA supports efforts to advance research on SARS-CoV2/COVID-19 by offering access to a large range of high containment in-vitro and in-vivo capacities

Read more

TNA call

ERINHA provides free of charge access to high containment and complementary facilities through ISIDORe Access Calls.

Read more

Value to Europe

European Bio-containment capacity enabling Europe to address the challenges posed by high-consequence pathogens

Read more

Collaborative projects

ERINHA both participates and coordinates European and international projects

Read more

ERINHA's concept

European distributed research infrastructure of Bio Safety Level 3 and 4 (BSL3 & BSL4) facilities providing access to perform large-scale research projects
Read more

Scientific strategy

From Discovery to Prevention: ERINHA’s Research Approach
Read more

Pathogens We Study

ERINHA focuses on high-consequence pathogens of Risk Group 4 with no available countermeasures and high transmission and mortality rates
Read more

Unique facilities and scientists

The cutting edge research performed at ERINHA is made possible by a range of highly specialised European bio-contained facilities and unique expertise
Read more

"ERINHA was created by foresighted scientists who understood that infectious diseases will always be a major threat to humanity. They established this federation of high-containment facilities, forming a distributed European infrastructure. It is open to academic and industrial researchers globally, to facilitate the study of the most virulent pathogens, and to accelerate the development of much-needed diagnostics, therapeutics, and vaccines. The recurring outbreaks of Ebola virus disease, the spread of Crimean-Congo haemorrhagic fever virus, and the appearance of worrying new pathogens, show that these needs are ever-present. ERINHA, with its regional and global partners, will continue its mission to help ensure that Europe, and the world, is better prepared for future disease outbreaks."

Jonathan Ewbank, DG of ERINHA